BRCA2 and neoplasm: One tumor from a ST patient had a somatic missense mutation in BRCA2 (p.Pro2257Ser, MAF = 0.15) that is classified as tolerated and benign by SIFT (score = 0.12) and PolyPhen2 (score = 0.047), and therefore considered as non-pathogenic.